Nanotechnology |
|
| The Council of Canadian Academies has been asked by the federal Minister of Health: “What is the state of knowledge with respect to existing nanomaterial properties and their health and environmental risks, which could underpin regulatory perspectives on needs for research, risk assessment and surveillance?” An Expert Panel on Nanotechnology has been appointed by the Council of Canadian Academies to address this question. Scientific knowledge, or evidence, is broadly interpreted to include natural sciences and engineering, as well as social sciences. Assessment QuestionWhat is known about the risks that nanomaterials may pose to human health and the environment? Small
is Different: A Science Perspective on the Regulatory Challenges
of the Nanoscale THE EXPERT PANEL ON NANOTECHNOLOGYThe expert panel, chaired by Professor Pekka Sinervo (FRSC), held its first meeting on August 21, 2007 to discuss the question with the sponsoring department (Health Canada ); to agree on an outline for the assessment report; and to coordinate research and writing tasks. The report of the assessment is expected to be completed and made public in Spring, 2008. |
|
| Former Dean, Faculty of Arts and Science, University of Toronto (Toronto , ON) |
|
President, LithChi Inc. and Chairman, Société pour la promotion de la science et de la technologie (Montréal, QC) ) |
|
Professor of Philosophy and Director, Centre for Studies in Religion and Society, University of Victoria (Victoria , BC) |
|
Canada Research Chair in Science and Society and Director, Institute for Science, Society and Policy, University of Ottawa (Ottawa , ON) |
|
Assistant Professor, Institute of Biomaterials and Biomedical Engineering, University of Toronto (Toronto , ON) |
|
Distinguished R&D Staff Member and Group Leader, Atmospheric and Aerosol Science Group, Environmental Sciences Division, Oak Ridge National Laboratory (Oak Ridge , TN) |
|
Director, Centre for Intellectual
Property Policy and Associate Professor, Faculty of Law, McGill University
|
|
Professor, Department of Physics, McGill University (Montreal , QC) |
|
Senior Vice-President, Global Liability Line of Business Head, Zurich Insurance Companies (New York , NY) |
|
Chief Science Advisor, Project on Emerging Nanotechnologies, Woodrow Wilson International Center for Scholars (Washington , D.C.) |
|
Professor, Environmental Medicine, School of Medicine and Dentistry, University of Rochester (Rochester, NY) |
|
Author, Nanotechnology: Health and Environmental Risks and Managing Director, CLF Ventures (Boston , MA) |
|
Research Officer, National Institute for Nanotechnology; Research Associate, Health Law Institute, University of Alberta and Special Advisor, Strategic Development, Alberta Ingenuity Fund (Edmonton , AB) |
|
Adjunct Professor, Carleton University and President, Coleman, Bright and Associates (Ottawa , ON) |
|
Deputy Program Director for Science, National Toxicology Program, National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH) (Research Triangle Park , NC) |
|
|
|
|
PUBLIC CALL FOR EVIDENCE (Download PDF)The Expert Panel on Nanotechnology arranged for a Public call for Evidence to help the panel analyse and report on the question posed by the federal Minister of Health - "What is the state of knowledge with respect to existing nanomaterial properties and their health and environmental risks, which could underpin regulatory perspectives on needs for research, risk assessment and surveillance?” Responses were received until January 11, 2008. For further details on the Public Call for Evidence, please download the PDF. |
|
(2 MB)